ReviewFrontiers in oncology2026

Adjuvant endocrine therapy in estrogen-low breast cancer in the era of CDKI: are we at another uncertain crossroads?

Maria Rosaria Valerio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.